MH Guide CAS product webinar video – 2025-07-10
Intuitive by design, powerful in practice: MH Guide CAS for cancer research
Transforming biomedical data into actionable insights
Accelerated, accurate, multi-modal variant annotation and reporting – empowering molecular pathologists and researchers in oncology to act with confidence
Cut the hours you spend on variant annotation and evidence review – while keeping the final judgment in your hands.
In this live webinar, Molecular Health’s experts show how MH Guide CAS bridges the ‘last mile’ of NGS by:
- Automating ACMG pathogenicity & ClinGen/CGC/VICC oncogenicity evaluation and evidence level assignment (AMP/ASCO/CAP)
- Delivering panel and assay agnostic import of VCF data with state-of-the-art data security
- Taking advantage of MH’s quality assured and PhD expert-curated oncology knowledgebase
- Evaluating comprehensive biomarker insights, therapy associations, and geo matched clinical trials in seconds
- Combining NGS and non-NGS results for multi-modal reporting
- Taking care of cybersecurity, data residency and data hosting requirements
- Producing fully customizable summary reports that fit seamlessly into your downstream processes
Walk away with insights into how MH Guide CAS supports scalable precision in oncology research—whether you’re working with focused assays or broad CGP panels that include complex biomarkers such as MSI, TMB, and HRD.
Register today and discover how MH Guide CAS transforms tertiary NGS-analysis into a highly automated, secure, and actionable process.
(Can’t join live? Just register, and we’ll send you the on-demand recording so you can watch at your convenience.)
MH Guide CAS is offered by MH’s global strategic partner Integrated DNA Technologies (IDT) in the U.S., UK, and other non-EU or non-EFTA (European Free Trade Association) countries.
By registering for this webinar, you acknowledge and consent that your personal data may also be shared with our business partner Integrated DNA Technologies (IDT) for event-related purposes in accordance with applicable data-protection laws.
MH Guide Case Annotation Solution (MH Guide CAS) is for research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, Molecular Health does not intend this product to be used in clinical applications and does not warrant fitness or suitability of the product for any clinical diagnostic use. The purchaser is solely responsible for all decisions regarding the use of the product and any associated regulatory or legal obligations.